FOQUEST has now been included on the Ontario Drug Benefit (ODB) formulary as of April 28, 2023
Foquest has now been included on the Ontario Formulary, effective April 28, 2023. Foquest is covered as a General Benefit (with therapeutic notes) on the Ontario Drug Benefit (ODB) Formulary for the treatment of persons with Attention Deficit with/without Hyperactivity Disorder.
Learn more about the eligibility criteria for reimbursement of Foquest in Ontario.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.